Targeting non-conserved cysteines for allosteric inhibition of SHP2

被引：0
|
作者：
Kao, Lynn [1 ]
Kim, Jenny [1 ]
Bishop, Anthony [2 ]
机构：
[1] Amherst Coll, Amherst, MA 01002 USA
[2] Amherst Coll, Dept Chem, Amherst, MA 01002 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
225
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations
    Wildes, David
    Aay, Naing
    Buckl, Andreas
    Hsieh, Daphne
    Jogalekar, Ashutosh S.
    Kiss, Gert
    Koltun, Elena S.
    Marquez, Abby
    Mellem, Kevin T.
    Romero, Jason
    Saldajeno-Concar, Mae
    Schulze, Christopher J.
    Semko, Chris M.
    Won, Walter
    Nichols, Robert J.
    Stahlhut, Carlos
    Tzitzilonis, Christos
    Gill, Adrian L.
    Smith, Jacqueline A.
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
    Chen, Ying-Nan P.
    LaMarche, Matthew J.
    Chan, Ho Man
    Fekkes, Peter
    Garcia-Fortanet, Jorge
    Acker, Michael G.
    Antonakos, Brandon
    Chen, Christine Hiu-Tung
    Chen, Zhouliang
    Cooke, Vesselina G.
    Dobson, Jason R.
    Deng, Zhan
    Fei, Feng
    Firestone, Brant
    Fodor, Michelle
    Fridrich, Cary
    Gao, Hui
    Grunenfelder, Denise
    Hao, Huai-Xiang
    Jacob, Jaison
    Ho, Samuel
    Hsiao, Kathy
    Kang, Zhao B.
    Karki, Rajesh
    Kato, Mitsunori
    Larrow, Jay
    La Bonte, Laura R.
    Lenoir, Francois
    Liu, Gang
    Liu, Shumei
    Majumdar, Dyuti
    Meyer, Matthew J.
    Palermo, Mark
    Perez, Lawrence
    Pu, Minying
    Price, Edmund
    Quinn, Christopher
    Shakya, Subarna
    Shultz, Michael D.
    Slisz, Joanna
    Venkatesan, Kavitha
    Wang, Ping
    Warmuth, Markus
    Williams, Sarah
    Yang, Guizhi
    Yuan, Jing
    Zhang, Ji-Hu
    Zhu, Ping
    Ramsey, Timothy
    Keen, Nicholas J.
    NATURE, 2016, 535 (7610) : 148 - +
  • [23] Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
    Jonathan R. LaRochelle
    Michelle Fodor
    Vidyasiri Vemulapalli
    Morvarid Mohseni
    Ping Wang
    Travis Stams
    Matthew J. LaMarche
    Rajiv Chopra
    Michael G. Acker
    Stephen C. Blacklow
    Nature Communications, 9
  • [24] Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
    Ying-Nan P. Chen
    Matthew J. LaMarche
    Ho Man Chan
    Peter Fekkes
    Jorge Garcia-Fortanet
    Michael G. Acker
    Brandon Antonakos
    Christine Hiu-Tung Chen
    Zhouliang Chen
    Vesselina G. Cooke
    Jason R. Dobson
    Zhan Deng
    Feng Fei
    Brant Firestone
    Michelle Fodor
    Cary Fridrich
    Hui Gao
    Denise Grunenfelder
    Huai-Xiang Hao
    Jaison Jacob
    Samuel Ho
    Kathy Hsiao
    Zhao B. Kang
    Rajesh Karki
    Mitsunori Kato
    Jay Larrow
    Laura R. La Bonte
    Francois Lenoir
    Gang Liu
    Shumei Liu
    Dyuti Majumdar
    Matthew J. Meyer
    Mark Palermo
    Lawrence Perez
    Minying Pu
    Edmund Price
    Christopher Quinn
    Subarna Shakya
    Michael D. Shultz
    Joanna Slisz
    Kavitha Venkatesan
    Ping Wang
    Markus Warmuth
    Sarah Williams
    Guizhi Yang
    Jing Yuan
    Ji-Hu Zhang
    Ping Zhu
    Timothy Ramsey
    Nicholas J. Keen
    Nature, 2016, 535 : 148 - 152
  • [25] Thermodynamic and Kinetic Destabilization of Triosephosphate Isomerase Resulting from the Mutation of Conserved and Non-conserved Cysteines
    Eugenia Cruces-Angeles, Ma
    Cabrera, Nallely
    Perez-Montfort, Ruy
    Reyes-Lopez, Cesar A.
    Hernandez-Arana, Andres
    PROTEIN AND PEPTIDE LETTERS, 2011, 18 (12): : 1290 - 1298
  • [26] Allosteric SHP2 inhibition enhances regorafenib ' s effectiveness in colorectal cancer treatment
    Han, Xiao
    Wang, Weicheng
    Wang, Rui
    Zhang, Wei
    Zhu, Lijun
    Xu, Qiang
    Guo, Wenjie
    Gu, Yanhong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 709
  • [27] Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor
    Fortanet, Jorge Garcia
    Chen, Christine Hiu-Tung
    Chen, Ying-Nan P.
    Chen, Zhouliang
    Deng, Zhan
    Firestone, Brant
    Fekkes, Peter
    Fodor, Michelle
    Fortin, Pascal D.
    Fridrich, Cary
    Grunenfelder, Denise
    Ho, Samuel
    Kang, Zhao B.
    Karki, Rajesh
    Kato, Mitsunori
    Keen, Nick
    LaBonte, Laura R.
    Larrow, Jay
    Lenoir, Francois
    Liu, Gang
    Liu, Shumei
    Lombardo, Franco
    Majumdar, Dyuti
    Meyer, Matthew J.
    Palermo, Mark
    Perez, Lawrence
    Pu, Minying
    Ramsey, Timothy
    Sellers, William R.
    Shultz, Michael D.
    Stams, Travis
    Towler, Christopher
    Wang, Ping
    Williams, Sarah L.
    Zhang, Ji-Hu
    LaMarche, Matthew J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (17) : 7773 - 7782
  • [28] Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors
    Bagdanoff, Jeffrey T.
    Chen, Zhouliang
    Acker, Michael
    Chen, Ying-Nan
    Chan, Homan
    Dore, Michael
    Firestone, Brant
    Fodor, Michelle
    Fortanet, Jorge
    Hentemann, Murphy
    Kato, Mitsunori
    Koenig, Robert
    LaBonte, Laura R.
    Liu, Shumei
    Mohseni, Movarid
    Ntaganda, Rukundo
    Sarver, Patrick
    Smith, Troy
    Sendzik, Martin
    Stams, Travis
    Spence, Stan
    Towler, Christopher
    Wang, Hongyun
    Wang, Ping
    Williams, Sarah L.
    LaMarche, Matthew J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1781 - 1792
  • [29] Mechanisms of resistance to SHP2 inhibition
    Wei, Wei
    Geer, Mitchell
    Guo, Xinyi
    Sanjana, Neville
    Neel, Benjamin G.
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth
    Wang, Yuyi
    Salvucci, Ombretta
    Ohnuki, Hidetaka
    Tran, Andy D.
    Ha, Taekyu
    Feng, Jing-Xin
    DiPrima, Michael
    Kwak, Hyeongil
    Wang, Dunrui
    Yu, Yanlin
    Kruhlak, Michael
    Tosato, Giovanna
    EMBO MOLECULAR MEDICINE, 2021, 13 (07)
12345